Syndax Pharmaceuticals (SNDX) Tops Q1 EPS by 14c

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q1 EPS of ($0.48), $0.14 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $64.9 million versus the consensus estimate of $71.84 million.

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.

You May Also Be Interested In

• Paychex (PAYX) Tops Q1 EPS by 2c
• Samsung wins contracts with KT and SK Telecom for Korea AI RAN projects
• AutoZone (AZO) PT Lowered to $4,230 at UBS Following 'Underwhelming' Q4 Print